Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Non-Current Deffered Revenue (2025)

Camp4 Therapeutics' Non-Current Deffered Revenue history spans 1 years, with the latest figure at $8.1 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue changed N/A year-over-year to $8.1 million; the TTM value through Dec 2025 reached $8.1 million, changed N/A, while the annual FY2025 figure was $8.1 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $8.1 million at Camp4 Therapeutics.
  • Across five years, Non-Current Deffered Revenue topped out at $8.1 million in Q4 2025 and bottomed at $8.1 million in Q4 2025.